The Latest Breaking News from Generic Drugs

The Trump administration is reportedly planning to exclude imported generic drugs from tariffs.

As the demand for affordable healthcare options grows, the pharmaceutical industry is increasingly focused on developing generic drugs to expand access and reduce costs. This trend is driving major players to seek FDA approvals for generic versions of popular medications, reshaping the competitive landscape and providing more choices for consumers.

Union Health Ministry provides generic drugs to treat 4 rare diseases, slashing costs by 60-100 times. In process of making drugs for more rare diseases available in coming months. Sickle cell drug formulation for children also made available. 8.4-10 cr cases of rare diseases in India, 80% genetic. Health Ministry…

NMC suspends proposed regulations on prescribing generic drugs, ending stand-off between it and IMA. Health Ministry buys time for both parties, allowing doctors to prescribe drugs with generic names, but no penal provisions. IMA fears poor quality of generic drugs, while NMC says they are cheaper and can reduce health…

Indian Medical Association (IMA) demands government intervene to stop forcing doctors to prescribe generic drugs, citing quality concerns. It suggests ordering pharma companies to manufacture drugs without brand names. It questions why branded drugs should be licensed if doctors can't prescribe them.

The National Medical Commission (NMC) in its 'Regulations relating to Professional Conduct of Registered Medical Practitioners" also asked doctors to avoid prescribing branded generic drugs. Read further on Dynamite News:

Past public ire over high drug prices has recently taken a back seat to a more insidious problem – no drugs at any price.

The Jan Aushadhi Kendras selling generic drugs at affordable prices have seen their sales rise more than 170 times over the last nine years, but the government has no intention of making them available online in the near future.

The recent, abrupt shortage of critical cancer drugs is forcing doctors to ration essential medications. It highlights a broken business model in generic drugs.